Nanotechnology Platform for Ex Vivo Gene Therapy

Project Information

Problem

Current gene transfer technologies in cell therapy manufacturing are limited by specificity, size of insert, multiplexing capabilities, time, and cost.

Solution

This project uses nano-injection to develop more efficient gene transfer technology and engineer T cells for therapeutic treatments.

Technology Type

Diagnostic

Aids with identifying the nature and cause(s) of a clinical problem or illness

Facilitator

Increases the efficacy of a clinical process or procedure

Therapeutic

Enables healing from or treatment of an illness or clinical problem

Monitor

Records/shares data as on-going surveillance of a clinical problem, process or procedure

PI/Inventor(s)

Patrick Lundgren, MSc

Co-Founder and Immunology Graduate Student at the Perelman School of Medicine

Daniel Lundgren

Co-Founder

Haim Bau, PhD

Professor of Mechanical Engineering and Applied Mechanics

Penn Engineering

Chris Lo

Co-Founder

Company Formed

NanoXCell Therapeutics

Cohort

2018-2019